Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Looney

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|March 1, 1994
Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?D J Looney
Journal of Virology|July 11, 1998
CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cellsE M Poeschla, D J Looney
The New England Journal of Medicine|March 2, 1989
Actinomycotic tonsillitis with expectoration of sulfur granulesJ J Drabick, D J Looney
Human Gene Therapy|November 26, 1998
A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNAF Wong-Staal, E M Poeschla, D J Looney
Clinical and Experimental Immunology|February 1, 1991
Effect of a recombinant HIV gp160 vaccine on monokine productionD P Dooley, R A Cox, D J Looney
Nature Medicine|March 21, 1998
Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectorsE M Poeschla, F Wong-Staal, D J Looney
Journal of Virology|April 1, 1995
Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitroG Baier, G Baier-Bitterlich, D J Looney, et al.
Immunology Letters|October 2, 2001
Altered immunophenotype of dendritic cells generated from HIV infected subjectsA Gruber, D J Looney, M Ibanez, et al.
Journal of Virology|October 1, 1995
An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinantM Mamounas, D J Looney, R Talbott, et al.
The Journal of Clinical Investigation|May 1, 1994
Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cellsJ Corbeil, E Rapaport, D D Richman, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|March 1, 1994
Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?D J Looney
Journal of Virology|July 11, 1998
CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cellsE M Poeschla, D J Looney
The New England Journal of Medicine|March 2, 1989
Actinomycotic tonsillitis with expectoration of sulfur granulesJ J Drabick, D J Looney
Human Gene Therapy|November 26, 1998
A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNAF Wong-Staal, E M Poeschla, D J Looney
Clinical and Experimental Immunology|February 1, 1991
Effect of a recombinant HIV gp160 vaccine on monokine productionD P Dooley, R A Cox, D J Looney
Nature Medicine|March 21, 1998
Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectorsE M Poeschla, F Wong-Staal, D J Looney
Journal of Virology|April 1, 1995
Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitroG Baier, G Baier-Bitterlich, D J Looney, et al.
Immunology Letters|October 2, 2001
Altered immunophenotype of dendritic cells generated from HIV infected subjectsA Gruber, D J Looney, M Ibanez, et al.
Journal of Virology|October 1, 1995
An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinantM Mamounas, D J Looney, R Talbott, et al.
The Journal of Clinical Investigation|May 1, 1994
Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cellsJ Corbeil, E Rapaport, D D Richman, et al.
Pageof 4